Showing results (1551-1560 of 1,567) with videos related to
Sort By:
Pageof 157
IJID Regions|June 20, 2022
Seroprevalence of SARS-CoV-2 antibodies in Bangladesh related to novel coronavirus infectionTaufiqur Rahman Bhuiyan, Marjahan Akhtar, Aklima Akter, et al.Frontiers in Immunology|October 27, 2025
Multimodal reprogramming of the tumor microenvironment by MMR and dual checkpoint blockade in hepatocellular carcinoma modelsMulu Z Tesfay, Aleksandra Cios, Khandoker Usran Ferdous, et al.Plos Neglected Tropical Diseases|January 4, 2022
Disease characteristics and serological responses in patients with differing severity of COVID-19 infection: A longitudinal cohort study in Dhaka, BangladeshAfroza Akter, Tasnuva Ahmed, Imam Tauheed, et al.Nature Medicine|October 9, 2019
Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapseFrancesca Chemi, Dominic G Rothwell, Nicholas McGranahan, et al.Environmental Science and Pollution Research International|February 4, 2023
Assessing the Self-reported After Events Following Immunization of COVID-19 Vaccines in Turkey and BangladeshArifa Sultana, Sabiha Rahman Mim, Ananya Saha, et al.Genome Biology|January 12, 2026
SARS-CoV-2 wastewater genomic surveillance: approaches, challenges, and opportunitiesViorel Munteanu, Michael A Saldana, David Dreifuss, et al.Nature Medicine|June 5, 2020
Publisher Correction: Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapseFrancesca Chemi, Dominic G Rothwell, Nicholas McGranahan, et al.Molecular Therapy. Oncology|January 6, 2025
Enhancing immune response and survival in hepatocellular carcinoma with novel oncolytic Jurona virus and immune checkpoint blockadeMulu Z Tesfay, Yuguo Zhang, Khandoker U Ferdous, et al.Scientific Reports|May 13, 2017
Serum sonic hedgehog (SHH) and interleukin-(IL-6) as dual prognostic biomarkers in progressive metastatic breast cancerA S Noman, M Uddin, A A Chowdhury, et al.Nature Medicine|April 24, 2019
Utility of ctDNA to support patient selection for early phase clinical trials: the TARGET studyDominic G Rothwell, Mahmood Ayub, Natalie Cook, et al.Pageof 157